By: Jason Kindschy
Another win bites the dust.
The culprit of Rafael “Feijao” Cavalcante’s failed drug test was the anabolic steroid known as Stanozolol. The same drug that fellow Brazilian fighter Christine “Cyborg” Santos failed for in December of 2011.
The California State Athletic Commission announced today that “Feijao” failed for Stanozolol, he will be suspended for 1 year, face a $2,500 fine, and the win over Mike Kyle will be overturned to a no-contest. Cavalcante’s win over Kyle was on the night Strikeforce Heavyweight Grand Final back on May 19th in San Jose, California. The win came by way of guillotine choke, 33 seconds into the first round. This puts Rafael Cavalcante’s record at 11-3-1.
The win over Mike Kyle was allegedly going to put “Feijao” in line to fight Gegard Mousasi (32-3-2) for the vacant Strikeforce light-heavyweight title.
Stanozolol, also known as Winstrol, or Tenabol, derives from dihydrotestosterone, and is a commonly used performance enhancer by athletes of all kinds. All reputable athletic commissions and boards ban it across the globe. Stanozolol has even been used for horse racing in the U.S.
The CSAC says that Cavalcante was tested on May 18th, and CSAC executive officer George Dodd stated. “Anabolic agents and other banned substances put not only the users of those agents at risk, but their opponents as well. The commission simply will not tolerate their use.”
For all the latest MMA and UFC news BJPENN.com has got you covered!Tags: Chris Cyborg Santos, featured, Feijao Drug Test, Mike Kyle, MMA NEWS, Rafael Feijao Cavalcante, Stanozolol, Strikeforce, Strikeforce Heavyweight Grand Prix Final